Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County (Q45206670)

10 December 2017

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County (English)

1 reference

population-based cohort study

10 December 2017

0 references

1 reference

1 reference

Karen V Winther

1

1 reference

10 December 2017

Tine Jess

2

1 reference

10 December 2017

Ebbe Langholz

3

1 reference

10 December 2017

Pia Munkholm

4

1 reference

10 December 2017

Vibeke Binder

5

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Clinical Gastroenterology and Hepatology

10 December 2017

1 reference

10 December 2017

2

1 reference

10 December 2017

12

1 reference

10 December 2017

1088-1095

1 reference

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colorectal cancer complicating ulcerative colitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colorectal cancer prevention in ulcerative colitis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Prognosis of chronic ulcerative colitis in a community

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

The risk of colorectal cancer in ulcerative colitis. An epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colorectal cancer in patients with ulcerative colitis. A population study in central Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Ulcerative colitis and colorectal cancer. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Cancer in patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Extracolonic malignancies in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Hodgkin's disease risk is increased in patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Cancer risk in patients with inflammatory bowel disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colorectal cancer risk and mortality in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colorectal cancer in inflammatory bowel disease: a continuing problem

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Review article: maintenance of remission in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colonic epithelial dysplasia or carcinoma in a regional group of patients with ulcerative colitis of more than 15 years duration

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Prevalence of Hepatobiliary Dysfunction in a Regional Group of Patients with Chronic Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Extraintestinal cancers in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

Colorectal and extracolonic malignancy in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900543-9

7 January 2021

10.1016/S1542-3565(04)00543-9

Identifiers

DOI

1 reference

10 December 2017

1 reference